A Facebook post claiming that children with autism who took L-carnitine showed improvements in symptom severity, social behavior, communication, attention and cognitive function is circulating widely - and unlike some of the supplement claims we have fact-checked before, this one has real clinical trial evidence behind it. Here is what the research actually shows, and why it does not mean L-carnitine works the same way for every autistic person.
What the research actually shows
L-carnitine is a naturally occurring compound the body uses to transport fatty acids into mitochondria for energy production. A double-blind, randomized, placebo-controlled trial published in Medical Science Monitor gave 30 children with autism either liquid L-carnitine (50 mg per kilogram of body weight per day) or a placebo for three months. The treatment group showed statistically significant improvements on the Childhood Autism Rating Scale (CARS), the Clinical Global Impression scale, and the parent-reported Autism Treatment Evaluation Checklist. A separate study using a higher dose (100 mg/kg/day) over six months also reported significant improvement. These are real, peer-reviewed, controlled results - not anecdote.
Why it does not work the same for everyone
The trials also found that the size of the clinical improvement correlated with how much a child's blood carnitine levels actually rose - people who started out more deficient, and whose levels rose more, tended to improve more. That fits a broader pattern researchers have found: an estimated 20 percent or fewer of autistic people appear to have some form of impaired carnitine metabolism. Some of this traces back to a specific gene, TMLHE, involved in making carnitine in the body; a deficiency in this gene shows up in roughly 1 in 350 non-dysmorphic autistic boys. But the same research found that only about 3 percent of boys with the TMLHE deficiency go on to develop autism, meaning it is a risk factor that interacts with other things, not a single cause. In short: carnitine supplementation looks genuinely helpful for a subgroup with an underlying metabolic difference, not as a general treatment for autism itself.
Safety and practical caution
Across the published trials, L-carnitine was generally well tolerated, with mild digestive upset being the most commonly reported issue at higher doses. That said, the doses studied were calculated by body weight in children, under medical and laboratory supervision, sometimes alongside blood testing for carnitine levels before and during treatment. This is not the kind of supplement decision to make from a Facebook post: dosing a child based on body weight, without knowing whether they actually have a carnitine-related metabolic difference, is not what the research supports.
What to do if you are curious
If you want to explore this for your child, the right next step is a conversation with a pediatrician or geneticist, who can discuss whether metabolic or genetic testing makes sense before considering supplementation. For a broader look at the genetics researchers are studying in autism, see our article on autism genes and brain pathways, and our free Autism AQ-10 screening is a starting point for understanding traits, not a substitute for a metabolic workup.
Sources: Geier et al., "A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders," Medical Science Monitor (2011); Malaguarnera and Cauli, "Effects of L-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies," Molecules (2019); research on TMLHE gene deficiency and autism risk. Educational summary - not a diagnosis or medical advice.